1974
DOI: 10.1016/0010-7824(74)90099-7
|View full text |Cite
|
Sign up to set email alerts
|

Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
109
1
5

Year Published

1991
1991
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 219 publications
(115 citation statements)
references
References 9 publications
0
109
1
5
Order By: Relevance
“…Bioavailable testosterone was measured using the method of Tremblay and Dube [14] (normal values: mean = 7.87 nmol/l; range = 3.4±12.93 nmol/l). Intraassay coefficients of reliability for total testosterone and bioavailable testosterone were 3.0 % and 5.8 %, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…Bioavailable testosterone was measured using the method of Tremblay and Dube [14] (normal values: mean = 7.87 nmol/l; range = 3.4±12.93 nmol/l). Intraassay coefficients of reliability for total testosterone and bioavailable testosterone were 3.0 % and 5.8 %, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…Bioavailable estradiol and testosterone (the non-sex hormone-binding globulin (SHBG)-bound fractions) were measured by an adaptation of the Tremblay and Dube ammonium-sulfate precipitation method. 24 Adiponectin levels were measured on the same serum samples in 2004 by RIA at Linco Diagnostics Laboratory (St Louis, MO, USA). Linco reported no problems with two freeze-thaw cycles for the adiponectin assay.…”
Section: Blood Measuresmentioning
confidence: 99%
“…It has been shown that PAI-1 is of particular importance in CHD, with elevated levels predicting MI and progression of atherosclerosis in stable CHD patients (22,23). Crosssectional studies have reported a positive association between testosterone levels and tPA and a negative association with PAI-1, VIIc and fibrinogen (14,15,24). Replacement of testosterone in hypogonadal men and treatment of normal men with dehydroepiandrosterone (DHEA) reduces PAI-1 serum levels, whilst testosterone administration in healthy men also reduces plasma levels of the acute phase protein fibrinogen (23), which is an independent risk factor for CAD (25).…”
Section: Introductionmentioning
confidence: 99%